(5) established positive response to dopaminergic medication (at least 30% UPDRS-III improvement with levodopa)
Patients are encouraged to confirm their current regulatory status with their healthcare provider before proceeding
34x/week is optimal Use progressive overload: gradually increase weight, reps, or sets over time Do not replace resistance training with cardio add cardio on top of resistance training, not instead of it Consider creatine monohydrate supplementation (35g/day) for training support Supplementation Consider daily free-form EAA supplementation, additional servings can be taken between meals when protein targets are difficult to hit from food or before activity Consider omega-3 supplementation if fatty fish intake is low Monitor and address vitamin D, B12, and iron status through regular bloodwork Monitoring Track body composition (not just scale weight) through DEXA, BIA, or circumference measurements Monitor gym performance a sustained decline in strength is a meaningful warning sign Regular bloodwork for micronutrient status every 36 months while on GLP-1 therapy Summary GLP-1 receptor agonists including semaglutide and tirzepatide are highly effective for weight loss, but they create a nutritional environment where lean muscle mass is at significant risk
Sudden injuries from sparks or falls can limit movement, which in turn affects mitochondrial health and energy production inside your cells
These actions collectively contribute to better blood sugar control and reduced appetite
Because subcutaneous fat depth varies enormously between individuals the post cites a range from roughly 5 mm to over 25 mm depending on age, sex, body composition, and the site being used
